What is important to remember about measuring drug bioavailability?

What is important to remember about measuring drug bioavailability?

• A. Has to be indirect; Can't take tissue from patient to determine how much of the active ingredient is there
• B. Can be measured directly by analyzing tissue concentrations
• C. Is independent of route of administration
• D. Is always 100% for intravenous administration

Answer: (A)

Bioavailability is the fraction of the administered dose that reaches the systemic circulation. Because sampling tissue from patients to know exactly how much drug is in specific organs is invasive and often impractical, we measure bioavailability indirectly by looking at blood levels over time and using pharmacokinetic metrics like the area under the concentration–time curve (AUC) and Cmax to compare routes or formulations. This indirect approach captures the amount of drug that actually makes it into the bloodstream, which is the essence of bioavailability. Direct measurement of tissue drug levels isn't typically used for this purpose, and that's why bioavailability is assessed indirectly rather than by analyzing tissue concentrations. Route matters for bioavailability—intravenous administration is defined as having 100% systemic availability, but that definition doesn't change the need for indirect measurement methods when comparing other routes.

Bioavailability is the fraction of the administered dose that reaches the systemic circulation. Because sampling tissue from patients to know exactly how much drug is in specific organs is invasive and often impractical, we measure bioavailability indirectly by looking at blood levels over time and using pharmacokinetic metrics like the area under the concentration–time curve (AUC) and Cmax to compare routes or formulations. This indirect approach captures the amount of drug that actually makes it into the bloodstream, which is the essence of bioavailability. Direct measurement of tissue drug levels isn't typically used for this purpose, and that's why bioavailability is assessed indirectly rather than by analyzing tissue concentrations. Route matters for bioavailability—intravenous administration is defined as having 100% systemic availability, but that definition doesn't change the need for indirect measurement methods when comparing other routes.